We are live on ! Find out more
EC

Enhancing Capital Portfolio holdings

AUM $135M
1-Year Est. Return 25.85%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+25.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$5.55M
Cap. Flow
-$3.22M
Cap. Flow %
-2.35%
Top 10 Hldgs %
41.51%
Holding
94
New
2
Increased
20
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$697K
2
PLPC icon
Preformed Line Products
PLPC
+$327K
3
TMO icon
Thermo Fisher Scientific
TMO
+$243K
4
MA icon
Mastercard
MA
+$116K
5
AMZN icon
Amazon
AMZN
+$94.2K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.01M
2
GIS icon
General Mills
GIS
+$772K
3
APD icon
Air Products & Chemicals
APD
+$709K
4
IDR icon
Idaho Strategic Resources
IDR
+$633K
5
UNH icon
UnitedHealth
UNH
+$624K

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Financials 14.9%
3 Utilities 11.25%
4 Industrials 10.83%
5 Healthcare 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DPZ icon
51
Domino's
DPZ
$11.5B
$763K 0.56%
1,768
+33
+2% +$15K
PYPL icon
52
PayPal
PYPL
$49.6B
$704K 0.51%
10,495
-1,378
-12% -$97.1K
ESE icon
53
ESCO Technologies
ESE
$8.25B
$695K 0.51%
3,293
– –
HD icon
54
Home Depot
HD
$336B
$673K 0.49%
1,660
– –
PEG icon
55
Public Service Enterprise Group
PEG
$39.4B
$668K 0.49%
8,000
– –
LOW icon
56
Lowe's Companies
LOW
$118B
$628K 0.46%
2,500
– –
CSGP icon
57
CoStar Group
CSGP
$12.1B
$593K 0.43%
7,030
+150
+2% +$13.3K
BKNG icon
58
Booking.com
BKNG
$144B
$589K 0.43%
2,725
+150
+6% +$33.5K
ICE icon
59
Intercontinental Exchange
ICE
$83.5B
$557K 0.41%
3,307
+101
+3% +$18K
SHW icon
60
Sherwin-Williams
SHW
$80.3B
$526K 0.38%
1,519
+38
+3% +$13.4K
MAR icon
61
Marriott International
MAR
$100B
$521K 0.38%
2,000
– –
ABT icon
62
Abbott
ABT
$183B
$509K 0.37%
3,800
– –
ADSK icon
63
Autodesk
ADSK
$47.2B
$502K 0.37%
1,579
– –
CPRT icon
64
Copart
CPRT
$27.4B
$490K 0.36%
10,902
+932
+9% +$43.9K
UNFI icon
65
United Natural Foods
UNFI
$2.96B
$478K 0.35%
12,706
– –
ABBV icon
66
AbbVie
ABBV
$460B
$463K 0.34%
2,000
– –
WING icon
67
Wingstop
WING
$3.76B
$433K 0.32%
1,719
+171
+11% +$53.1K
MUSA icon
68
Murphy USA
MUSA
$11.4B
$431K 0.32%
1,109
+57
+5% +$22.6K
PG icon
69
Procter & Gamble
PG
$346B
$369K 0.27%
2,400
– –
PLPC icon
70
Preformed Line Products
PLPC
$1.49B
$365K 0.27%
+1,860
New +$327K
GPC icon
71
Genuine Parts
GPC
$17.6B
$362K 0.26%
2,610
– –
CTVA icon
72
Corteva
CTVA
$58.2B
$347K 0.25%
5,133
– –
TRV icon
73
Travelers Companies
TRV
$81.5B
$335K 0.25%
1,200
– –
CL icon
74
Colgate-Palmolive
CL
$73.3B
$320K 0.23%
4,000
– –
HSY icon
75
Hershey
HSY
$36B
$308K 0.23%
1,647
-863
-34% -$157K
1 2
3
4

Similar funds

UOP
University of Pittsburgh Pittsburgh, Pennsylvania $135M AUM 29.36% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
ICM
Isabella Capital Management London $135M AUM
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $135M AUM 10.83% 1-Year Est. Return
SG
Somerset Group Wayzata, Minnesota $135M AUM 21.18% 1-Year Est. Return

Enhancing Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Enhancing Capital held 94 positions worth $137M, up 4.2% from $131M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Enhancing Capital's Q3 2025 filing shows 2 new, 20 increased, 7 reduced and 7 closed positions. Its largest new stake was Preformed Line Products: 1,860 shares worth $365K. The largest sale was Pfizer, an estimated $1.01M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Utilities.

  • Enhancing Capital's largest Q3 2025 buy was Preformed Line Products: 1,860 shares worth $365K.
  • Enhancing Capital added most to NVIDIA in Q3 2025, an estimated $697K increase.
  • Enhancing Capital's biggest Q3 2025 reduction was Idaho Strategic Resources, cutting an estimated $633K.
  • Enhancing Capital fully exited Pfizer in Q3 2025, selling an estimated $1.01M.
  • Enhancing Capital's ten largest holdings make up 42% of its $137M portfolio in Q3 2025.
  • Enhancing Capital opened 2 new positions and closed 7 in Q3 2025.
  • Enhancing Capital's portfolio value rose 4.2% quarter-over-quarter to $137M.

Based on Enhancing Capital's 13F filing for Q3 2025, filed 13 Nov 2025.